BTLA Antikörper
-
- Target Alle BTLA Antikörper anzeigen
- BTLA (B and T Lymphocyte Associated (BTLA))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BTLA Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Kreuzreaktivität
- Human
- Produktmerkmale
-
Rabbit Polyclonal antibody to CD272 (B and T lymphocyte associated)
CD272 antibody - Aufreinigung
- Purified by antigen-affinity chromatography.
- Immunogen
- Recombinant protein encompassing a sequence within the center region of human CD272. The exact sequence is proprietary.
- Isotyp
- IgG
- Top Product
- Discover our top product BTLA Primärantikörper
-
anti-B and T Lymphocyte Associated (BTLA) antibody
BTLA Reaktivität: Human WB, FACS Wirt: Maus Monoclonal 2E4 unconjugated
anti-B and T Lymphocyte Associated (BTLA) (AA 30-183) antibodyBTLA Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-B and T Lymphocyte Associated (BTLA) (AA 31-157) antibodyBTLA Reaktivität: Human WB, ELISA, FACS, IHC, ICC, Neut Wirt: Maus Monoclonal 5G1G10 unconjugated
anti-B and T Lymphocyte Associated (BTLA) (AA 179-289) antibodyBTLA Reaktivität: Human WB, ELISA, FACS, IHC, ICC, Neut Wirt: Maus Monoclonal 7H3E3 unconjugated
anti-B and T Lymphocyte Associated (BTLA) (AA 221-289) antibodyBTLA Reaktivität: Human, Maus WB, ELISA, FACS, ICC, IHC (p), IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-B and T Lymphocyte Associated (BTLA) antibodyBTLA Reaktivität: Human WB, FACS, IF Wirt: Maus Monoclonal 2G2 unconjugated
anti-B and T Lymphocyte Associated (BTLA) (AA 101-150) antibodyBTLA Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-B and T Lymphocyte Associated (BTLA) antibodyBTLA Reaktivität: Human, Non-Human Primate FACS Wirt: Maus Monoclonal MIH26 unconjugated
anti-B and T Lymphocyte Associated (BTLA) (AA 30-183) antibodyBTLA Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-B and T Lymphocyte Associated (BTLA) antibody (PE)BTLA Reaktivität: Human, Non-Human Primate FACS Wirt: Maus Monoclonal MIH26 PE
-
- Applikationshinweise
- WB: 1:500-1:3000. IHC-P: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
- Kommentare
-
Positive Control: A375
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- 0.1M Tris-Glycine ( pH 7), 10 % Glycerol, 0.01 % Thimerosal
- Konservierungsmittel
- Thimerosal (Merthiolate)
- Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
- Target
- BTLA (B and T Lymphocyte Associated (BTLA))
- Andere Bezeichnung
- B and T lymphocyte associated (BTLA Produkte)
- Synonyme
- BTLA antikoerper, BTLA1 antikoerper, CD272 antikoerper, A630002H24 antikoerper, B and T lymphocyte associated antikoerper, BTLA antikoerper, Btla antikoerper
- Molekulargewicht
- 33 kDa
- Gen-ID
- 151888
- UniProt
- Q7Z6A9
- Pathways
- Cancer Immune Checkpoints
-
